Belinda Borrelli1. 1. Centers for Behavioral and Preventive Medicine, The Miriam Hospital, Providence, RI 02903, USA. belinda_borrelli@brown.edu
Abstract
OBJECTIVES: To discuss methods of preservation of treatment fidelity in health behavior change trials conducted in public health contexts. METHODS: The treatment fidelity framework provided by the National Institutes of Health's Behavioral Change Consortium includes five domains of treatment fidelity (Study Design, Training, Delivery, Receipt, and Enactment). A measure of treatment fidelity was previously developed and validated using these categories. RESULTS: Strategies for assessment, monitoring, and enhancing treatment fidelity within each of the five treatment fidelity domains are discussed. The previously created measure of treatment fidelity is updated to include additional items on selecting providers, additional confounders, theory testing, and multicultural considerations. CONCLUSIONS: Implementation of a treatment fidelity plan may require extra staff time and costs. However, the economic and scientific costs of lack of attention to treatment fidelity are far greater than the costs of treatment fidelity implementation. Maintaining high levels of treatment fidelity with flexible adaptation according to setting, provider, and patient is the goal for public health trials.
OBJECTIVES: To discuss methods of preservation of treatment fidelity in health behavior change trials conducted in public health contexts. METHODS: The treatment fidelity framework provided by the National Institutes of Health's Behavioral Change Consortium includes five domains of treatment fidelity (Study Design, Training, Delivery, Receipt, and Enactment). A measure of treatment fidelity was previously developed and validated using these categories. RESULTS: Strategies for assessment, monitoring, and enhancing treatment fidelity within each of the five treatment fidelity domains are discussed. The previously created measure of treatment fidelity is updated to include additional items on selecting providers, additional confounders, theory testing, and multicultural considerations. CONCLUSIONS: Implementation of a treatment fidelity plan may require extra staff time and costs. However, the economic and scientific costs of lack of attention to treatment fidelity are far greater than the costs of treatment fidelity implementation. Maintaining high levels of treatment fidelity with flexible adaptation according to setting, provider, and patient is the goal for public health trials.
Authors: Jeanette Waxmonsky; Amy M Kilbourne; David E Goodrich; Kristina M Nord; Zongshan Lai; Christina Laird; Julia Clogston; Hyungjin Myra Kim; Christopher Miller; Mark S Bauer Journal: Psychiatr Serv Date: 2014-01-01 Impact factor: 3.084
Authors: Anita Y Kinney; Rachel Howell; Rachel Ruckman; Jean A McDougall; Tawny W Boyce; Belinda Vicuña; Ji-Hyun Lee; Dolores D Guest; Randi Rycroft; Patricia A Valverde; Kristina M Gallegos; Angela Meisner; Charles L Wiggins; Antoinette Stroup; Lisa E Paddock; Scott T Walters Journal: Contemp Clin Trials Date: 2018-09-18 Impact factor: 2.226
Authors: Ryan J Shaw; Dori M Steinberg; Leah L Zullig; Hayden B Bosworth; Constance M Johnson; Linda L Davis Journal: J Am Med Inform Assoc Date: 2014-05-22 Impact factor: 4.497
Authors: Barbara K Campbell; Allison Buti; Holly E Fussell; Priya Srikanth; Dennis McCarty; Joseph R Guydish Journal: Am J Drug Alcohol Abuse Date: 2013-07-09 Impact factor: 3.829
Authors: Catherine J Binkley; Knowlton W Johnson; Melissa Abadi; Kirsten Thompson; Stephen R Shamblen; Linda Young; Brigit Zaksek Journal: Eval Program Plann Date: 2014-07-27